ATE464899T1 - Verwendung von canthin-6-on und seiner analoga bei der behandlung von erkrankungen durch mycobakterien - Google Patents

Verwendung von canthin-6-on und seiner analoga bei der behandlung von erkrankungen durch mycobakterien

Info

Publication number
ATE464899T1
ATE464899T1 AT07731175T AT07731175T ATE464899T1 AT E464899 T1 ATE464899 T1 AT E464899T1 AT 07731175 T AT07731175 T AT 07731175T AT 07731175 T AT07731175 T AT 07731175T AT E464899 T1 ATE464899 T1 AT E464899T1
Authority
AT
Austria
Prior art keywords
canthin
mycobacteria
analogues
treatment
diseases caused
Prior art date
Application number
AT07731175T
Other languages
English (en)
Inventor
Alain Fournet
Delphine Lagoutte
Erwan Poupon
Flor Soriano-Agaton
Original Assignee
Inst Rech Developpement Ird
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Rech Developpement Ird filed Critical Inst Rech Developpement Ird
Application granted granted Critical
Publication of ATE464899T1 publication Critical patent/ATE464899T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/16—Peri-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT07731175T 2006-03-28 2007-03-22 Verwendung von canthin-6-on und seiner analoga bei der behandlung von erkrankungen durch mycobakterien ATE464899T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0602677A FR2899229B1 (fr) 2006-03-28 2006-03-28 Utilisation de la canthin-6-one et ses analogues dans le traitement des pathologies liees aux micobacteries
PCT/FR2007/000486 WO2007110500A1 (fr) 2006-03-28 2007-03-22 Utilisation de la canthin-6-one et ses analogues dans le traitement des pathologies liees aux mycobacteries

Publications (1)

Publication Number Publication Date
ATE464899T1 true ATE464899T1 (de) 2010-05-15

Family

ID=36979514

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07731175T ATE464899T1 (de) 2006-03-28 2007-03-22 Verwendung von canthin-6-on und seiner analoga bei der behandlung von erkrankungen durch mycobakterien

Country Status (9)

Country Link
US (1) US20110059977A1 (de)
EP (1) EP1998770B1 (de)
CN (1) CN101448499B (de)
AP (1) AP2721A (de)
AT (1) ATE464899T1 (de)
BR (1) BRPI0709673A2 (de)
DE (1) DE602007005992D1 (de)
FR (1) FR2899229B1 (de)
WO (1) WO2007110500A1 (de)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8203367A1 (es) * 1980-07-03 1982-04-01 Omnichem Sa Procedimiento de preparacion de alquil-3 tetrahidro-1,2,3, 3a-4h-indolo(3,2,1-de)-1,5-naftiridinas.
AU2002307204A1 (en) * 2001-04-06 2002-10-21 The Regents Of The University Of California Inhibitors of acyl glucosaminyl inositol amidase and methods of use
FR2847474B1 (fr) * 2002-11-25 2006-03-24 Inst Rech Developpement Ird Utilisation de la canthin-6-one, des extraits de plantes la contenant et de ses derives dans le traitement de la maladie de chagas

Also Published As

Publication number Publication date
EP1998770A1 (de) 2008-12-10
WO2007110500A8 (fr) 2008-12-11
AP2008004644A0 (en) 2008-10-31
FR2899229A1 (fr) 2007-10-05
AP2721A (en) 2013-08-31
BRPI0709673A2 (pt) 2011-07-19
CN101448499A (zh) 2009-06-03
WO2007110500A1 (fr) 2007-10-04
EP1998770B1 (de) 2010-04-21
DE602007005992D1 (de) 2010-06-02
CN101448499B (zh) 2012-09-05
US20110059977A1 (en) 2011-03-10
FR2899229B1 (fr) 2008-05-30

Similar Documents

Publication Publication Date Title
ATE519488T1 (de) Aminopyrazin-analoga zur behandlung von glaukomen und anderen durch rho-kinase verursachten krankheiten
ATE448206T1 (de) Benzochinazolinderivate und ihre verwendung bei der behandlung von knochenerkrankungen
DE602005005810D1 (de) Verwendung von substituierten chinolin-derivaten zur behandlung von arzneimittelresistenten mycobakteriellen erkrankungen
DE602005023172D1 (de) Hydantoinderivate zur behandlung von entzündlichen erkrankungen
ATE474578T1 (de) Verwendung von flibanserin bei der behandlung von prämenstruellen störungen
ATE524479T1 (de) Sulfonamidthiazolpyridinderivate als zur behandlung von typ-2-diabetes geeignete glucokinaseaktivatoren
ATE434620T1 (de) Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen
DE602006018583D1 (de) Verfahren und zusammensetzung zur behandlung von peripheren gefässkrankheiten
CR10699A (es) Antagonistas de wnt y su uso en el diagnostico y tratamiento de trastornos mediados por wnt
DE602005026984D1 (de) Chinolin-derivate zur behandlung von latenter tuberkulose
EA200870019A1 (ru) Лактамовые соединения и способы их применения
ATE499105T1 (de) Behandlung oder vorbeugung von haut- oder gewebezuständen bei tieren unter verwendung von boryloxypyridylmethanonen
ATE512663T1 (de) Kombination zur behandlung von erkrankungen mit zellproliferation
NO20081842L (no) Fremgangsmåter og sammensetninger for anvendelse ved behandling av pasienter med autoantistoff-positive sykdommer
ITMI20050262A1 (it) Sostanze composizioni e metodi di trattamento dell'alopecia
ATE495179T1 (de) Tetrahydropyridothienpyrimidin-verbindungen und verwendung zur behandlung proliferativer erkrankungen
DE602006006354D1 (de) Pinolensäure zur Behandlung von Übergewicht
ATE524183T1 (de) Verwendung von sanglifehrin bei der hcv-therapie
ATE489091T1 (de) Dha-ester und ihre verwendung bei der behandlung und der prävention von kardiovaskulären erkrankungen
CL2007003038A1 (es) Compuestos derivados de 2-fenil-6-aminocarbonil-pirimidina; composicion farmaceutica; y uso en el tratamiento de trastornos vasculares oclusivos.
ATE483460T1 (de) Amino-oxo-indolyliden-verbindungen zur verwendung in der behandlung von juckender kopfhaut
ATE542804T1 (de) 5-phenyl-pentansäurederivate als matrixmetalloproteinase-inhibitoren zur behandlung von asthma und anderen erkrankungen
DE602006007323D1 (de) VERWENDUNG VON BAFF ZUR BEHANDLUNG Th2-INDUZIERTER LEIDEN
DE602005016141D1 (de) S-mirtazapin zur behandlung von hitzewallungen
ATE449769T1 (de) 3-(4-ää4-(4ää3-(3,3-dimethyl-1- piperidinyl)propyläoxyüphinylü-1- piperidinylcarbonylü-1-naphthalinyl)propan- oder propensäure als h1- und h3-rezeptor-antagonisten zur behandlung entzündlicher und/oder allergischer erkrankungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties